Press Releases on November 6, 2023 - EIN Presswire - Press Release Distribution Service

Published on November 6, 2023 - 13:00 GMT

Genevant Sciences to Collaborate with Novo Nordisk to Develop Gene Editing Treatment for Hemophilia A

VANCOUVER, British Columbia, and BASEL, Switzerland, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and an expansive lipid nanoparticle (LNP) patent portfolio, today announced that it …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on November 6, 2023 - 13:00 GMT

Vertex conclut un partenariat avec Shopify pour simplifier la conformité aux règles fiscales à l'échelle mondiale

KING OF PRUSSIA, État de Pennsylvanie, 06 nov. 2023 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ :VERX), ci-après « Vertex » ou « la Société », fournisseur mondial de technologies dans le domaine fiscal, annonce aujourd'hui la conclusion d’un partenariat …

Distribution channels: Companies, Media, Advertising & PR ...

Published on November 6, 2023 - 13:00 GMT

TransUnion Report Shows Fraud Attacks on Financial Industry Call Centers Rising

CHICAGO, Nov. 06, 2023 (GLOBE NEWSWIRE) -- At a time when commerce is increasingly conducted digitally, consumers still expect and rely on call centers to deliver timely and trustworthy customer service when they need it. However, according to a new …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on November 6, 2023 - 13:00 GMT

Provectus Biopharmaceuticals Announces Presentation of Preclinical PV-10 Vaccine Adjuvant Data at Society for Immunotherapy of ...

KNOXVILLE, TN, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that preclinical data from ongoing research on the potential use of investigational cancer immunotherapy PV-10 (rose bengal sodium) as an adjuvant in vaccines to help …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on November 6, 2023 - 13:00 GMT

Abacus Life Launches New Wealth Division – ABL Wealth – in Association with Dynasty Financial Partners

ORLANDO, Fla. and BOCA RATON, Fla., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading buyer of life insurance policies and vertically-integrated alternative asset manager specializing in specialty …

Distribution channels: Insurance Industry, Media, Advertising & PR ...

Published on November 6, 2023 - 13:00 GMT

New Report: Virtual Events Surpass Both Hybrid and In-Person Events

New York, NY, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Kaltura (Nasdaq: KLTR), the Video Experience Cloud, today released two new reports “The State of Events”, and “The State of Webinars”. The reports, based on global surveys of hundreds of marketers, provide a …

Distribution channels: IT Industry, Media, Advertising & PR ...

Published on November 6, 2023 - 13:00 GMT

Music Licensing, Inc. (OTC:SONG) Takes Bold Strides Towards Shareholder Value with the Cancellation of 1,566,945,290 Common Shares,...

Naples, FL, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Music Licensing, Inc. (OTC: SONG), a trailblazer in the music industry, is thrilled to announce a groundbreaking development that will electrify our shareholders and the entire market. Our visionary CEO, Jake P …

Distribution channels:

Published on November 6, 2023 - 13:00 GMT

Velatura HIE Corporation Announces Hire of Noelle Parker

Jefferson City, Mo., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Velatura HIE Corporation (Velatura), a not-for-profit organization offering affiliation, collaboration, and integration opportunities to health information exchanges (HIEs) across the country, today …

Distribution channels: Media, Advertising & PR ...

Published on November 6, 2023 - 13:00 GMT

Madrigal Pharmaceuticals Provides Corporate Updates and Reports Third Quarter 2023 Financial Results

Priority Review of resmetirom new drug application underway in the U.S. Bill Sibold appointed Chief Executive Officer of Madrigal in September 2023 $500 million financing provides Madrigal with funds to support a potential first-to-market launch of …

Distribution channels:

Published on November 6, 2023 - 13:00 GMT

ORYZON to Provide Corporate Progress Updates at Several Events in November

BIO-Europe 2023 LSX Investival Showcase 2023 Jefferies London Healthcare Conference 2023 MADRID, Spain and BOSTON, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on November 6, 2023 - 13:00 GMT

CymaBay Therapeutics to Present at Upcoming Investment Conferences

NEWARK, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on innovative therapies for patients with liver and other chronic diseases, today announced that members of its management team …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on November 6, 2023 - 13:00 GMT

Soleno Therapeutics Announces Peer-Reviewed Publication of Results from Long-Term Open-Label Study of DCCR in Prader-Willi ...

REDWOOD CITY, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced publication of one- …

Distribution channels: Media, Advertising & PR, Technology ...

Published on November 6, 2023 - 13:00 GMT

In Historic Move, Medicare Proposes Preliminary Reimbursement Level for ReWalk Personal Exoskeleton

Preliminary payment determination of $94,617 does not yet factor in currently available ReWalk system with Breakthrough Device Designation. CMS welcomes additional pricing materials at upcoming HCPCS meeting to reflect subsequent advancements in technology …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on November 6, 2023 - 13:00 GMT

Post Holdings’ President and CEO Rob Vitale to Take Medical Leave of Absence

ST. LOUIS, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Post Holdings, Inc. (NYSE: Post) (“Post”), a consumer packaged goods holding company, today announced that President and Chief Executive Officer Robert V. Vitale will be taking an unexpected medical leave of …

Distribution channels: Companies, Food & Beverage Industry ...

Published on November 6, 2023 - 13:00 GMT

Indaptus Therapeutics’ Decoy20 Demonstrated a Broad Immune Response of More than Fifty Cytokines and Chemokines in Patients ...

NEW YORK, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical biopharma company that utilizes a proprietary killed, non-pathogenic bacteria-based platform to generate a stabilized package of immune agonists to activate …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on November 6, 2023 - 13:00 GMT

Mindera Health ™ announces the signing of a commercial agreement with Occum Health for Mind.Px ™

San Diego, CA, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Mindera Health today announces the signing a commercial agreement with Occum Health, LLC, a healthcare solutions company that is focused on delivering savings and improved benefits to self-insured employers. …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on November 6, 2023 - 13:00 GMT

Post Holdings Provides Preliminary Unaudited Selected Financial Data for Fourth Quarter of Fiscal Year 2023; Issues Fiscal Year ...

ST. LOUIS, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Post Holdings, Inc. (NYSE:POST) today provided certain preliminary unaudited selected financial data for the fourth quarter of fiscal year 2023 and issued its outlook for fiscal year 2024. This release should be …

Distribution channels:

Published on November 6, 2023 - 13:00 GMT

ENZO BIOCHEM REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS AND PROVIDES BUSINESS UPDATE

FARMINGDALE, NY, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fourth quarter ended July 31, 2023, and the fiscal year ended July 31, 2023, and also provided a general …

Distribution channels:

Published on November 6, 2023 - 13:00 GMT

Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors

REHOVOT, Israel and MONMOUTH JUNCTION, N.J., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on November 6, 2023 - 13:00 GMT

Immutep Announces Completion of the Safety Lead-In and Opening of the Randomized Phase II of the AIPAC-003 Phase II/III Trial in ...

Media Release No safety or tolerability issues in open-label, safety lead-in phase evaluating the higher 90mg dose of efti in combination with weekly paclitaxel in the first 6 patients Good safety profile allows for lead-in phase to be closed early and the …

Distribution channels: Technology ...